World Wires · story 11041 · unverified · 1 source(s)

Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer

Leader in targeted immuno-oncology drug development brings three decades of academic and biopharmaceutical oncology expertise

Open in the desk

Coverage

• Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer GlobeNewswire: public companies · tier D · clear net · 2026-09-30 20:10 UTC

What this site indexes